Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anu Jacob

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Seizure|May 9, 2012
Refractory coeliac disease associated with late onset epilepsy, ataxia, tremor and progressive myoclonus with giant cortical evoked potentials--a case report and review of literatureSaqib Javed, Asimah Safdar, Allan Forster, et al.
JAMA Neurology|March 19, 2014
Transverse myelitis associated with an itchy rash and hyperckemia: neuromyelitis optica associated with dermatitis herpetiformisAnand Iyer, Devipriya Rathnasabapathi, Liene Elsone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2012
Neuropathic pruritus (itch) in neuromyelitis opticaLiene Elsone, Tristan Townsend, Kerry Mutch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2012
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidenceAnu Jacob, Samira Saadoun, Joanna Kitley, et al.
Journal of Neurology|October 19, 2019
Correction to: Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief reviewJayne L Chamberlain, Saif Huda, Daniel H Whittam, et al.
Journal of Neurology|November 15, 2021
Correction to: Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief reviewJayne L Chamberlain, Saif Huda, Daniel H Whittam, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 26, 2017
IgLON5 disease responsive to immunotherapyMichael Bonello, Anu Jacob, Mark A Ellul, et al.
Multiple Sclerosis and Related Disorders|June 26, 2024
Disease modifying treatment guidelines for multiple sclerosis in the United Arab EmiratesAnu Jacob, Ahmed Osman Shatila, Jihad Inshasi, et al.
Orphanet Journal of Rare Diseases|April 8, 2022
Health utilities and costs for neuromyelitis optica spectrum disorderDyfrig A Hughes, Siobhan Bourke, Angela Jones, et al.
Journal of Neurology|September 5, 2019
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief reviewJayne L Chamberlain, Saif Huda, Daniel H Whittam, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Seizure|May 9, 2012
Refractory coeliac disease associated with late onset epilepsy, ataxia, tremor and progressive myoclonus with giant cortical evoked potentials--a case report and review of literatureSaqib Javed, Asimah Safdar, Allan Forster, et al.
JAMA Neurology|March 19, 2014
Transverse myelitis associated with an itchy rash and hyperckemia: neuromyelitis optica associated with dermatitis herpetiformisAnand Iyer, Devipriya Rathnasabapathi, Liene Elsone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2012
Neuropathic pruritus (itch) in neuromyelitis opticaLiene Elsone, Tristan Townsend, Kerry Mutch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2012
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidenceAnu Jacob, Samira Saadoun, Joanna Kitley, et al.
Journal of Neurology|October 19, 2019
Correction to: Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief reviewJayne L Chamberlain, Saif Huda, Daniel H Whittam, et al.
Journal of Neurology|November 15, 2021
Correction to: Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief reviewJayne L Chamberlain, Saif Huda, Daniel H Whittam, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 26, 2017
IgLON5 disease responsive to immunotherapyMichael Bonello, Anu Jacob, Mark A Ellul, et al.
Multiple Sclerosis and Related Disorders|June 26, 2024
Disease modifying treatment guidelines for multiple sclerosis in the United Arab EmiratesAnu Jacob, Ahmed Osman Shatila, Jihad Inshasi, et al.
Orphanet Journal of Rare Diseases|April 8, 2022
Health utilities and costs for neuromyelitis optica spectrum disorderDyfrig A Hughes, Siobhan Bourke, Angela Jones, et al.
Journal of Neurology|September 5, 2019
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief reviewJayne L Chamberlain, Saif Huda, Daniel H Whittam, et al.
Pageof 15